Empowering People Through Proteomics
A new approach to
understanding and combating age-related disease
Teal is a biotechnology company developing platform technology to deepen our understanding of how we age. Our mission is to reshape healthcare by developing new approaches for measuring, monitoring, and treating age-related diseases. Through a novel understanding of aging, enabled by advanced proteomics, genomics, and artificial intelligence, we aim to accelerate the development of novel biomarkers and therapeutics that will enable precision medicine aimed at preventing age-related diseases.
Teal's platform has been developed through years of research by the Wyss-Coray lab at Stanford University and is built on previous discoveries that proteins found in the blood provide powerful insights into your body's functional state, biological age, and risk of disease.
Teal’s technology builds on over
25 years of academic research conducted in Stanford University's Wyss-Coray lab. The lab has focused is on brain aging and neurodegeneration with a specific interest in age-related cognitive decline and Alzheimer’s disease. From this work, it was discovered that circulatory blood factors can modulate brain structure and function and factors from young organisms can rejuvenate old brains.
Teal's science was built on the belief that a better understanding of aging biology will ultimately lead to insights that will accelerate the identification of new approaches for treating aging and age-related disease and their work focuses on the use of human proteomics as a tool for understanding aging and measuring health.
Tony Wyss-Coray, Phd
Chair of the Board
Jarod Rutledge, PhD